BONESUPPORT™ develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT®. The company portfolio includes CERAMENT® G with gentamicin, and CERAMENT® V with vancomycin. Today more than 55,000 patients have been treated with products from the CERAMENT platform. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver and a Premarket approval filing with the FDA (USA) for its gentamicin eluting product is planned in 2021. The company is based in Lund, Sweden.
Please visit www.bonesupport.com for more information.
BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.
About Johnson & Johnson Medical Devices Companies
At Johnson & Johnson Medical Devices Companies, we are helping people live their best lives. Building on more than a century of expertise, we tackle pressing healthcare challenges, and take bold steps that lead to new standards of care while improving people’s healthcare experiences. In surgery, orthopaedics, vision and interventional solutions, we are helping to save lives and paving the way to a healthier future for everyone, everywhere.
About DePuy Synthes
DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, provides one of the most comprehensive orthopedics portfolios in the world. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide.
A new perspective in TAR
Anatomical: The components are designed to mimic patients’ natural anatomy. The curved talar component was created to align with the trabecular bone structure, and the tibia to provide anatomic cortical coverage and account for fibular articulation.
Fixation: The tibia’s press-fit bone cage and plasma pegs create initial fixation, while the talar component’s curve-on-curve shape and the anterior pegs are designed to provide A/P and M/L stability.
Biomechanics: A CT study of the healthy talus led to the articular design of the talar component that allows for anatomic replication of the natural ankle biomechanics.
Bone Removal: The radius of the curvature on the underside of the talus is based on studies that analyze the effect of arthritis, reducing the amount of talar preparation required.
Reliability: The innovative tibial design and surgical technique preserve the integrity of the tibia anterior cortex while the anterior talar shield provides increased surface area that addresses subsidence.
Visit us at our website:
The Standing CT Company is a partnership with Orthopaedic surgeons and Radiologists. We are the leading provider of mobile weight-bearing CT scanning in the UK. Our scanners are used at numerous UK institutions including RNOH, ROH, Royal Surrey, Barts Health, HCA and The Hospital of St Johns and St Elizabeth to significantly improve the imaging of feet and ankles, knees, hips and upper extremities. The scanners allow bilateral 3-dimensional imaging in a single 30 second pass with a low radiation dose equivalent to an X-Ray set.
We believe that innovation in medical technology is one of the key routes to better outcomes for patients. We exist to do good in healthcare - improving experiences for patients, providing leading-edge technology for clinicians, and working in partnership with our customers - in order to do well in business. We believe that having ethics at our core makes us a sustainable and profitable business, and we hope other healthcare providers to the NHS will follow our example.
Visit us at our website: